Authors:
NEMUNAITIS J
BUCKNER CD
DORSEY KS
WILLIS D
MEYER W
APPELBAUM F
Citation: J. Nemunaitis et al., RETROSPECTIVE ANALYSIS OF INFECTIOUS-DISEASE IN PATIENTS WHO RECEIVEDRECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR VERSUS PATIENTS NOT RECEIVING A CYTOKINE WHO UNDERWENT AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR TREATMENT OF LYMPHOID CANCER, American journal of clinical oncology, 21(4), 1998, pp. 341-346
Authors:
MARTIN P
NASH R
SANDERS J
LEISENRING W
ANASETTI C
DEEG HJ
STORB R
APPELBAUM F
Citation: P. Martin et al., REPRODUCIBILITY IN RETROSPECTIVE GRADING OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC MARROW TRANSPLANTATION, Bone marrow transplantation, 21(3), 1998, pp. 273-279
Authors:
ROWLEY SD
LOKEN M
RADICH J
KUNKLE LA
MILLS BJ
GOOLEY T
HOLMBERG L
MCSWEENEY P
BEACH K
MACLEOD B
APPELBAUM F
BENSINGER WI
Citation: Sd. Rowley et al., ISOLATION OF CD34(-CELL COMPONENTS USING THE BAXTER ISOLEX SYSTEM() CELLS FROM BLOOD STEM), Bone marrow transplantation, 21(12), 1998, pp. 1253-1262
Authors:
HANSEN JA
GOOLEY TA
MARTIN PJ
APPELBAUM F
CHAUNCEY TR
CLIFT RA
PETERSDORF EW
RADICH J
SANDERS JE
STORB RF
SULLIVAN KM
ANASETTI C
Citation: Ja. Hansen et al., BONE-MARROW TRANSPLANTS FROM UNRELATED DONORS FOR PATIENTS WITH CHRONIC MYELOID-LEUKEMIA, The New England journal of medicine, 338(14), 1998, pp. 962-968
Authors:
HIGANO CS
CHIELENS D
RASKIND W
BRYANT E
FLOWERS MED
RADICH J
CLIFT R
APPELBAUM F
Citation: Cs. Higano et al., USE OF INTERFERON-ALPHA-2A TO TREAT CYTOGENETIC RELAPSE OF CHRONIC MYELOID-LEUKEMIA AFTER MARROW TRANSPLANTATION, Blood, 90(7), 1997, pp. 2549-2554
Authors:
FURLONG T
STORB R
ANASETTI C
APPELBAUM F
DEEG HJ
DONEY K
MARTIN P
SULLIVAN KM
WITHERSPOON R
NASH RA
Citation: T. Furlong et al., CONVERSION TO FK506 FOR CYCLOSPORINE (CSP)-RESISTANT ACUTE GVHD OR CSP-ASSOCIATED TOXICITY, Blood, 90(10), 1997, pp. 458-458
Authors:
NASH R
KURZROCK R
DIPERSIO J
NIMER S
VOSE J
MAHARAJ D
LINKER C
NADEMANEE A
NEGRIN R
ASHBY M
TREMBLAY T
JONES D
APPELBAUM F
CHAMPLIN R
Citation: R. Nash et al., SAFETY AND ACTIVITY OF RECOMBINANT HUMAN THROMBOPOIETIN (RHTPO) IN PATIENTS (PTS) WITH DELAYED PLATELET RECOVERY (DPR), Blood, 90(10), 1997, pp. 1151-1151
Authors:
HOLMBERG LA
DEMIRER T
SCIFFMAN K
ROWLEY SD
BUCKNER CD
GOODMAN G
MAZIARZ R
APPELBAUM F
BENSINGER WI
Citation: La. Holmberg et al., HIGH-DOSE BUSULFAN, MELPHALAN AND THIOTEPA (BUMELTT) FOLLOWED BY AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELLS (PBSC) RESCUE IN PATIENTS WITH ADVANCED-STAGE III IV OVARIAN-CANCER/, Blood, 90(10), 1997, pp. 1705-1705
Authors:
FLOWERS MED
ZANIS J
PASQUINI R
DEEG HJ
RIBEIRO R
LONGTON G
MEDEIROS CR
DONEY K
SANDERS J
BRYANT E
HANSEN J
SULLIVAN KM
APPELBAUM F
THOMAS ED
STORB R
Citation: Med. Flowers et al., MARROW TRANSPLANTATION FOR FANCONI-ANEMIA - CONDITIONING WITH REDUCEDDOSES OF CYCLOPHOSPHAMIDE WITHOUT RADIATION, British Journal of Haematology, 92(3), 1996, pp. 699-706
Authors:
FLOWERS MED
TAPSCOTT SJ
EMERSON J
EMERSON MV
REAGAN T
TAYLOR L
AJER T
SIADAK M
SANDERS J
ZWINGENBERGER K
WILLSMANN K
APPELBAUM F
SULLIVAN KM
Citation: Med. Flowers et al., INCIDENCE OF PERIPHERAL NEUROPATHY (PN) PRIOR TO THALIDOMIDE TREATMENT FOR CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD), Blood, 88(10), 1996, pp. 2423-2423
Authors:
GREVER M
KOPECKY K
FOUCAR MK
HEAD D
BENNETT JM
HUTCHISON RE
CORBETT WEN
CASSILETH PA
HABERMANN T
GOLOMB H
RAI K
EISENHAUER E
APPELBAUM F
CHESON BD
Citation: M. Grever et al., RANDOMIZED COMPARISON OF PENTOSTATIN VERSUS INTERFERON ALFA-2A IN PREVIOUSLY UNTREATED PATIENTS WITH HAIRY-CELL LEUKEMIA - AN INTERGROUP STUDY, Journal of clinical oncology, 13(4), 1995, pp. 974-982
Authors:
BENSINGER W
APPELBAUM F
ROWLEY S
STORB R
SANDERS J
LILLEBY K
GOOLEY T
DEMIRER T
SCHIFFMAN K
WEAVER C
CLIFT R
CHAUNCEY T
KLARNET J
MONTGOMERY P
PETERSDORF S
WEIDEN P
WITHERSPOON R
BUCKNER CD
Citation: W. Bensinger et al., FACTORS THAT INFLUENCE COLLECTION AND ENGRAFTMENT OF AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELLS, Journal of clinical oncology, 13(10), 1995, pp. 2547-2555
Citation: M. Grever et al., OPTIMAL TREATMENT FOR UNTREATED PATIENTS WITH HAIRY-CELL LEUKEMIA - REPLY, Journal of clinical oncology, 13(10), 1995, pp. 2678-2679
Authors:
NEMUNAITIS J
ROSENFELD CS
ASH R
FREEDMAN MH
DEEG HJ
APPELBAUM F
SINGER JW
FLOMENBERG N
DALTON W
ELFENBEIN GJ
RIFKIN R
RUBIN A
AGOSTI J
HAYES FA
HOLCENBERG J
SHADDUCK RK
Citation: J. Nemunaitis et al., PHASE-III RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF RHGM-CSF FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 15(6), 1995, pp. 949-954
Authors:
THOMPSON D
SULLIVAN K
SEIDEL K
ERICKSON K
FLOWERS M
SIADAK M
APPELBAUM F
OLERUD J
STORB R
Citation: D. Thompson et al., PUVA AS ADJUVANT PRIMARY OR SALVAGE TREATMENT FOR CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD), Journal of investigative dermatology, 104(4), 1995, pp. 659-659
Authors:
NEMUNAITIS J
BUCKNER CD
DORSEY KS
WILLIS D
MEYER W
APPELBAUM F
Citation: J. Nemunaitis et al., RETROSPECTIVE ANALYSIS OF INFECTIOUS-DISEASE IN PATIENTS WHO RECEIVEDLEUKINE VERSUS PATIENTS NOT RECEIVING A CYTOKINE WHO UNDERWENT AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) FOR TREATMENT OF LYMPHOID CANCER, Blood, 86(10), 1995, pp. 871-871
Authors:
THOMPSON D
SULLIVAN K
SEIDEL K
ERICKSON K
FLOWERS M
SIADAK M
APPELBAUM F
OLERUD J
STORB R
Citation: D. Thompson et al., PUVA AS ADJUVANT PRIMARY OR SALVAGE TREATMENT FOR CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD), Blood, 86(10), 1995, pp. 1581-1581
Authors:
SULLIVAN KM
MARTIN P
BUCKNER CD
BEACH K
HIGANO T
RADICH J
CLIFT R
BENSINGER W
DEEG HJ
CHAUNCEY T
ROWLEY S
STORB R
APPELBAUM F
Citation: Km. Sullivan et al., G-CSF STIMULATED DONOR PERIPHERAL-BLOOD INFUSION(S) AS IMMUNOTHERAPY IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES RELAPSING AFTER ALLOGENEIC TRANSPLANTATION, Blood, 86(10), 1995, pp. 2242-2242
Authors:
BENSINGER WI
LONGIN K
APPELBAUM F
ROWLEY S
WEAVER C
LILLEBY K
GOOLEY T
LYNCH M
HIGANO T
KLARNET J
CHAUNCEY T
STORB R
BUCKNER CD
Citation: Wi. Bensinger et al., PERIPHERAL-BLOOD STEM-CELLS (PBSCS) COLLECTED AFTER RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR (RHG-CSF) - AN ANALYSIS OF FACTORS CORRELATING WITH THE TEMPO OF ENGRAFTMENT AFTER TRANSPLANTATION, British Journal of Haematology, 87(4), 1994, pp. 825-831
Authors:
NASH RA
MCSWEENEY PA
STORB R
GOOLEY T
FURLONG T
APPELBAUM F
DEEG HJ
DONEY K
MARTIN P
SULLIVAN K
WITHERSPOON R
ZAGER RA
HANSEN JA
ANASETTI C
Citation: Ra. Nash et al., FK506 IN COMBINATION WITH METHOTREXATE (MTX) FOR THE PREVENTION OF GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER MARROW TRANSPLANTATION FROM PHENOTYPICALLY HLA-IDENTICAL UNRELATED DONORS, Blood, 84(10), 1994, pp. 10000394-10000394
Authors:
STORB R
LEISENRING W
DEEG HJ
ANASETTI C
APPELBAUM F
BENSINGER W
BUCKNER CD
CLIFT R
DONEY K
HANSEN J
MARTIN P
SANDERS J
STEWART P
SULLIVAN K
THOMAS ED
WITHERSPOON R
Citation: R. Storb et al., LONG-TERM FOLLOW-UP OF A RANDOMIZED TRIAL OF GRAFT-VERSUS-HOST DISEASE PREVENTION BY METHOTREXATE CYCLOSPORINE VERSUS METHOTREXATE ALONE INPATIENTS GIVEN MARROW GRAFTS FOR SEVERE APLASTIC-ANEMIA/, Blood, 83(9), 1994, pp. 2749-2750
Authors:
BESINGER W
TESH D
APPELBAUM F
CLIFT R
STORB R
HANSEN J
BUCKNER D
Citation: W. Besinger et al., PHASE-I STUDY OF TOTAL-BODY IRRADIATION WITH LIVER AND LUNG SHIELDING, BUSULFAN (BU) AND CYCLOPHOSPHAMIDE (CY) IN PREPARATION FOR MARROW TRANSPLANT FOR MULTIPLE-MYELOMA (MM), Experimental hematology, 21(8), 1993, pp. 1110-1110